VIDOTIN 4 mg 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

vidotin 4 mg

gedeon richter romania s.a. - perindoprilum - compr. - 4mg - inhibitori ai enzimei de conversie a angiotensinei inhibitori ai enzimei de conversie a angiotensinei

VIDOTIN 8 mg 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

vidotin 8 mg

gedeon richter romania s.a. - perindoprilum - compr. - 8mg - inhibitori ai enzimei de conversie a angiotensinei inhibitori ai enzimei de conversie a angiotensinei

Pluvicto 欧盟 - 罗马尼亚文 - EMA (European Medicines Agency)

pluvicto

novartis europharm limited  - lutetium (177lu) vipivotide tetraxetan - neoplasmele prostatice, rezistent la castrare - produse radiofarmaceutice terapeutice - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.

PLUVICTO 1 000 MBq/ml 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

pluvicto 1 000 mbq/ml

advanced accelerator applications (italy) s.r.l. - italia - lutetium (177lu) vipivotida tetraxetan - sol inj./perf. - 1000mbq/ml - alte radiofarmaceutice de uz terapeutic diferite radiofarmaceutice de uz terapeutic